Uspehi Molekularnoj Onkologii

Aims & Scope

The main objective of the journal Advances in Molecular Oncology is publication of current information on basic, clinical and experimental research in molecular oncology.

The publication aim to provide insight into currently important areas of modern molecular oncology; present the most significant studies from Russian and foreign specialists in this field; create a forum for various researchers, including oncologists, molecular biologists, geneticists, biochemists, virologists, chemotherapists to share the results of their scientific research.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology, Medicine and Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Prevention of malignant neoplasms

  Citation: 14

  Authors: D. G., D. M.

• STUDY OF THE LEVEL OF FATTY ACIDS IN ERYTHROCYTE MEMBRANES AND SERUM OF PATIENTS WITH COLORECTAL CANCER IN NOVOSIBIRSK

  Citation: 12

  Authors: M. V., V. N., Ya. I., A. A., M. V., A. S.

• Epstein–Barr virus in the ethnic Tatars population: the infection and sequence variants of LMP1 oncogene

  Citation: 11

  Authors: K. V., N. B., I. V., T. E., A. K., A. A., S. V., A. V., V. E.

• Influence of DNA-binding compounds with cancer preventive activity on the mechanisms of gene expression regulation

  Citation: 9

  Authors: K. I., O. A., T. I., R. G., E. A., G. A., K., M. G.

• Differential expression of microRNAs and their target genes in cervical intraepithelial neoplasias of varying severity

  Citation: 7

  Authors: T. A., D. V., E. A., D. S.

• Biochemical markers of bone metastasis

  Citation: 7

  Authors: N. V., N. E.

• Relation of EGFR/PI3K/AKT signaling components with tamoxifen efficacy in patients with estrogen-dependent breast cancer

  Citation: 6

  Authors: T. A., N. N., M. V., S. V., E. M., N. V., J. G.

• Second primary malignancies of cancer patients: treatment-related carcinogenesis

  Citation: 6

  Authors: G. A., E. A., K. I., M. G.

• Neuroendocrine tumors of the lung: the current classification and pathology diagnosis algorithm

  Citation: 6

  Authors: V. V.

• Features of some transcription factors gene expression in the malignancy tissues of the corpus uteri

  Citation: 6

  Authors: D. S., I. S., O. I.